Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment

Richard L Hauger1, J Alberto Olivares-Reyes, Sandra Braun

  • 1Center of Excellence for Stress and Mental Health, San Diego VA Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA; Department of Psychiatry, School of Medicine, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA 92093, USA.

Regulatory Peptides
|July 4, 2013
PubMed

Insights

Agonist type dictates corticotropin-releasing factor receptor 2-alpha (CRF2(a)) desensitization. Urocortins rapidly desensitize CRF2(a) receptors, while CRF shows slower effects, revealing agonist-specific signaling pathways.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Endocrinology

Background:

  • Corticotropin-releasing factor receptors (CRFRs) mediate stress responses.
  • CRF2(a) receptor signaling is crucial for regulating physiological stress.
  • Understanding agonist-specific receptor regulation is key to deciphering stress pathways.

Purpose of the Study:

  • To investigate how different agonists regulate corticotropin-releasing factor receptor 2-alpha (CRF2(a)) function.
  • To elucidate the mechanisms underlying CRF2(a) receptor desensitization by various ligands.
  • To determine the role of beta-arrestin 2 in CRF2(a) receptor signaling.

Main Methods:

  • Utilized human retinoblastoma Y79 and transfected HEK293/U2OS cells.
  • Assessed receptor desensitization, phosphorylation, and internalization.
  • Investigated beta-arrestin 2 translocation and its impact on Gs-coupled signaling.

Main Results:

  • Selective agonists (UCN2, UCN3) caused rapid CRF2(a) receptor desensitization; CRF showed slower desensitization.
  • CRF1 receptor desensitization did not affect CRF2(a) signaling, and vice versa.
  • Beta-arrestin 2 recruitment was agonist-dependent and restrained Gs-coupled CRF2(a) signaling.

Conclusions:

  • Agonist-specific mechanisms govern CRF2(a) receptor desensitization rates and extent.
  • Beta-arrestin 2 plays a critical role in modulating CRF2(a) receptor signaling.
  • Differential regulation of CRF2(a) receptors by agonists impacts stress response pathways.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...